Last Price
12.30
Today's Change
+0.11 (0.90%)
Day's Change
11.99 - 12.42
Trading Volume
4,988,736
Overview
Market Cap
9 Billion
Shares Outstanding
739 Million
Avg Volume
4,727,177
Avg Price (50 Days)
11.14
Avg Price (200 Days)
10.83
PE Ratio
2.15
EPS
5.73
Earnings Announcement
11-Nov-2024
Previous Close
12.19
Open
12.18
Day's Range
11.99 - 12.42
Year Range
8.245 - 13.24
Trading Volume
4,988,736
Price Change Highlight
1 Day Change
0.90%
5 Day Change
0.57%
1 Month Change
20.94%
3 Month Change
17.48%
6 Month Change
10.31%
Ytd Change
8.37%
1 Year Change
5.13%
3 Year Change
23.37%
5 Year Change
18.27%
10 Year Change
18.27%
Max Change
18.27%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
US Services Activity Expands at Modest Pace for a Second Month
3
CEO Morning Brief
4
CEO Morning Brief
5
CEO Morning Brief
Ultra-rich Families Set to Control US$9.5 Tril by 2030, Says Deloitte
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
